News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
AOL.com Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CO2 Energy Transition Corp. (NOEM) reported a net income of $327,572 for Q2 2026, a decrease from $418,891 in Q2 2025, with diluted earnings per share at $0.03. The special-purpose acquisition company (SPAC) is focused on energy transition opportunities and is engaged in identifying …
A shareholder of NSIT (INSIGHT ENTERPRISES INC) has filed a Form 144 to sell up to 4,000 common shares through Merrill Lynch on NASDAQ. The aggregate market value of these shares is $618,000, with an approximate sale date of August 13, 2026. The filing …
Insight Enterprises (NSIT) stock reached a new 52-week high of $156.60, reflecting strong investor confidence and robust performance with a 90% year-to-date return. The company reported strong Q2 2026 financial results, surpassing Wall Street expectations, and received an increased price target from Raymond James. …
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong …
Insight Enterprises (NSIT) saw its shares jump after strong Q2 2026 results, driven by demand for AI infrastructure and cloud services, leading to raised full-year guidance. While analysts widely consider the stock overvalued at $107.50 compared to its current price of $154.74, Simply Wall …
Intensity Therapeutics (Nasdaq:INTS) is a late-stage clinical biotechnology company focused on developing INT230-6 for cancer treatment. The company recently provided updates on its INVINCIBLE-4 study for triple-negative breast cancer and the INVINCIBLE-3 study for soft tissue sarcoma, with preliminary positive results and plans for …
Assenagon Asset Management S.A. significantly increased its stake in Insight Enterprises, Inc. (NASDAQ:NSIT) by 34.6% in the second quarter, bringing its total holdings to $7.40 million. This move is part of a broader trend of institutional investors expanding their positions in Insight Enterprises, reflecting …
Insight Enterprises's Q2 Earnings Call: Our Top 5 Analyst Questions Insight Enterprises delivered results for Q2 that surpassed Wall Street's expectations, with management highlighting robust demand for infrastructure hardware and continued momentum in cloud and core services. CEO Jack Azagury cited over 20% growth …
Intensity Therapeutics reported a net loss of $3.0 million for Q2 2026 and held $9.5 million in cash. The company resumed limited clinical activities for its INVINCIBLE-3 and INVINCIBLE-4 trials, with preliminary INVINCIBLE-4 data showing promising results in pathological complete response and reduced adverse …
Intensity Therapeutics (INTS) reported a wider-than-expected Q2 2026 loss of $1.11 per share, missing analyst estimates by $0.24, causing its shares to fall 4.62% premarket. The clinical-stage biotech is advancing its INVINCIBLE-3 and INVINCIBLE-4 cancer trials, having secured over $23 million in funding over …
Earnings Call Insights: Intensity Therapeutics (INTS) Q2 2026 MANAGEMENT VIEW * "It is my pleasure to provide the latest update of our company's progress in the INVINCIBLE-3 and INVINCIBLE-4 studies, our business development activities, and our plans for the second half of 2026" (Founder, …
This article reports that Intensity Therapeutics Inc. filed a Form 8K on August 11, 2026. The Form 8K is a crucial document used by public companies to notify investors of significant events that shareholders should know about. No specific details about the content of …
INTENSITY THERAPEUTICS, INC. reported a net loss of $(3.0M) for Q2 2026, an increase from $(2.5M) in Q2 2025, with a diluted loss per share of $(1.11). The company remains pre-revenue but has made progress in its clinical programs, including initiating Phase 3 and …
The California State Teachers Retirement System significantly increased its stake in Insight Enterprises (
Insight Enterprises (NASDAQ:NSIT) reached a new 52-week high after JPMorgan Chase & Co. raised its price target from $135 to $160, maintaining a neutral rating. The company reported strong quarterly earnings of $3.86 EPS on $2.40 billion in revenue, exceeding analyst estimates. Despite the …
NSIT Q2 Deep Dive: AI Infrastructure and Operational Focus Drive Outperformance IT solutions integrator Insight Enterprises (NASDAQ:NSIT) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 14.7% year on year to $2.40 billion. Its non-GAAP profit of $3.86 per share …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Insight Enterprises stock has had a strong run so far this year, yet the current share price sits below where a Discounted Cash …
Insight Enterprises reported past second-quarter 2026 results showing revenue of US$2,399.5 million and net income of US$77.57 million, with basic EPS from continuing operations rising to US$2.58 from US$1.48 a year earlier. The company's earnings were supported by strong demand for AI-ready infrastructure and …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why Insight Enterprises Stock Is Back In Focus Insight Enterprises (NSIT) is back on investor watch after reporting second quarter 2026 earnings and impairment charges on a …
This article analyzes Insight Enterprises, Inc.'s recent financial performance, highlighting that the company surpassed analyst estimates for its latest quarter. It also provides a forward-looking perspective by detailing what analysts are forecasting for the company's performance in the upcoming year. The content will likely …
Insight Enterprises (NSIT) stock remained flat despite reporting strong Q2 2026 earnings, including a 65% increase in net income and a 29% rise in adjusted EBITDA, driven by high-margin AI and cloud work. The market's muted reaction suggests investors are still evaluating whether the …
Insight Enterprises Inc. (NSIT) reported strong Q2 2026 earnings, with adjusted diluted EPS soaring 44% and net revenue increasing by 15%. This growth was primarily driven by a 39% increase in cloud gross profit and a 21% rise in hardware revenue, especially in AI-ready …
Intensity Therapeutics (INTS.US) is scheduled to release its earnings report on August 11. This announcement provides key information about the upcoming financial disclosure for the company. Investors and analysts will be anticipating the report for insights into the company's performance.
Search by ticker symbol or company name and select a result to open its chart.